Zhou Y - Search Results

1

The application of histone deacetylases inhibitors in glioblastoma.

Chen R, Zhang M, Zhou Y, Guo W, Yi M, Zhang Z, Ding Y, Wang Y. Chen R, et al. Among authors: zhou y. J Exp Clin Cancer Res. 2020 Jul 18;39(1):138. doi: 10.1186/s13046-020-01643-6. J Exp Clin Cancer Res. 2020. PMID: 32682428 Free PMC article. Review.

2

Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic Value.

Zhou Y, Yang L, Zhang X, Chen R, Chen X, Tang W, Zhang M. Zhou Y, et al. Biomed Res Int. 2019 Apr 15;2019:6581576. doi: 10.1155/2019/6581576. eCollection 2019. Biomed Res Int. 2019. PMID: 31119182 Free PMC article.

3

NAMPT: A potential prognostic and therapeutic biomarker in patients with glioblastoma.

Guo Q, Han N, Shi L, Yang L, Zhang X, Zhou Y, Yu S, Zhang M. Guo Q, et al. Among authors: zhou y. Oncol Rep. 2019 Sep;42(3):963-972. doi: 10.3892/or.2019.7227. Epub 2019 Jul 10. Oncol Rep. 2019. PMID: 31322259 Free PMC article.

4

LncRNA MATN1-AS1 prevents glioblastoma cell from proliferation and invasion via RELA regulation and MAPK signaling pathway.

Han N, Yang L, Zhang X, Zhou Y, Chen R, Yu Y, Dong Z, Zhang M. Han N, et al. Among authors: zhou y. Ann Transl Med. 2019 Dec;7(23):784. doi: 10.21037/atm.2019.11.36. Ann Transl Med. 2019. PMID: 32042800 Free PMC article.

5

ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.

Yang L, Han N, Zhang X, Zhou Y, Chen R, Zhang M. Yang L, et al. Among authors: zhou y. Oncol Rep. 2020 Jun;43(6):1831-1844. doi: 10.3892/or.2020.7573. Epub 2020 Apr 2. Oncol Rep. 2020. PMID: 32323832 Free PMC article.

6

Effects of gross tumor volume and radiation dose on survival and locoregional recurrence in early-stage extranodal NK/T-cell lymphoma treated with intensity-modulated radiation therapy.

Zhou YM, Liu X, Yang Y, Wang SL, Fang H, Song YW, Liu YP, Jin J, Li N, Lu NN, Jing H, Tang Y, Chen B, Zhang WW, Zhai YR, Men K, Dai JR, Deng M, Qi SN, Li YX. Zhou YM, et al. J Cancer Res Clin Oncol. 2023 Jul;149(8):5219-5230. doi: 10.1007/s00432-022-04472-6. Epub 2022 Nov 14. J Cancer Res Clin Oncol. 2023. PMID: 36374333

7

Validation of the "obturator functioning scale" for Chinese-speaking patients with obturator prostheses after cancer-related maxillectomy.

Shang JW, Tian YY, Xu ZY, Liu XM, Cao Y, Sui L, Mao C, Zhou YS, Liu CL, Ye HQ, Yan YB. Shang JW, et al. Among authors: zhou ys. Heliyon. 2024 May 11;10(10):e31071. doi: 10.1016/j.heliyon.2024.e31071. eCollection 2024 May 30. Heliyon. 2024. PMID: 38803891 Free PMC article.

8

Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma.

Zhou Y, Mo S, Cui H, Sun R, Zhang W, Zhuang X, Xu E, Li H, Cheng Y, Meng Y, Liu M, Yan T, Liu H, Zhang L, Yang B, Xi Y, Wang S, Cheng X, Li S, Liu Z, Zhan Q, Hu Z, Cui Y. Zhou Y, et al. Natl Sci Rev. 2024 Apr 23;11(5):nwae150. doi: 10.1093/nsr/nwae150. eCollection 2024 May. Natl Sci Rev. 2024. PMID: 38803565 Free PMC article.

9

Zhou Y, Yang Z, Zeng H. Zhou Y, et al. Pharmgenomics Pers Med. 2024 May 23;17:251-270. doi: 10.2147/PGPM.S450960. eCollection 2024. Pharmgenomics Pers Med. 2024. PMID: 38803444 Free PMC article.

10

Pregnant outcomes of patients with positive anticentromere antibodies receiving in vitro fertilization-embryo transfer.

Tian Y, Zhou Y, Fan Y, Chen S, Guo X, Yu Y, Wu X, Xu W, Shu J. Tian Y, et al. Among authors: zhou y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 May 27:1-9. doi: 10.3724/zdxbyxb-2023-0559. Online ahead of print. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38803288 Chinese, English.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,406 results

Search Page